SAGE

Sage Therapeutics
SAGE

Overview Fund Activity
Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

224 hedge funds and large institutions have $7.19B invested in Sage Therapeutics in 2017 Q4 according to their latest regulatory filings, with 79 funds opening new positions, 72 increasing their positions, 63 reducing their positions, and 28 closing their positions.

Holders
224
Holders Change
+50
Holders Change %
+28.74%
% of All Funds
5.09%
Holding in Top 10
10
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+233.33%
% of All Funds
0.23%
New
79
Increased
72
Reduced
63
Closed
28
Calls
$303M
Puts
$264M
Net Calls
+$38.8M
Net Calls Change
+$81.5M

Top Buyers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$1.04B
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$1.03B
3
MWNA
3
Marshall Wace North America
New York
$105M
4
TGI
4
TRV GP II
Massachusetts
$90.2M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$552M

Top Sellers

1
Bank of New York Mellon
1
Bank of New York Mellon
New York
$267M
2
Federated Hermes
2
Federated Hermes
Pennsylvania
$1.71M
3
ORI
3
Oak Ridge Investments
Illinois
$57.1M
4
O
4
OppenheimerFunds
New York
$244M
5
Deutsche Bank
5
Deutsche Bank
Germany
$25M
Name Market Value Shares Shares
Change 		Shares
Change %
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$1.04B 6,311,317 +1,643,958 +35%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$1.03B 6,237,519 +621,357 +11%
BlackRock
3
BlackRock
New York
$567M 3,444,171 +486,135 +16%
Vanguard Group
4
Vanguard Group
Pennsylvania
$552M 3,352,445 +522,193 +18%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$341M 2,069,005 +369,796 +22%
Bank of New York Mellon
6
Bank of New York Mellon
New York
$267M 1,620,611 -1,089,416 -40%
O
7
OppenheimerFunds
New York
$244M 1,479,531 -314,473 -18%
State Street
8
State Street
Massachusetts
$185M 1,123,672 -119,093 -10%
BB
9
BB Biotech
Switzerland
$172M 1,042,439 -50,000 -5%
PAI
10
Palo Alto Investors
California
$134M 810,806 +23,555 +3%
JPMorgan Chase & Co
11
JPMorgan Chase & Co
New York
$130M 787,307 -50,787 -6%
Jennison Associates
12
Jennison Associates
New York
$112M 678,707 -195,043 -22%
Lord, Abbett & Co
13
Lord, Abbett & Co
New Jersey
$111M 671,535 +395,870 +144%
MWNA
14
Marshall Wace North America
New York
$105M 637,017 +580,056 +1,018%
EAM
15
Eagle Asset Management
Florida
$102M 619,028 -8,003 -1%
BBA
16
Baker Bros. Advisors
New York
$102M 616,514 +211,029 +52%
AllianceBernstein
17
AllianceBernstein
Tennessee
$95.7M 580,982 -23,237 -4%
TGI
18
TRV GP II
Massachusetts
$90.2M 547,916 +547,916 New
Franklin Resources
19
Franklin Resources
California
$86.4M 524,590 +50,254 +11%
PAMU
20
Pictet Asset Management (UK)
United Kingdom
$77.4M 469,610 +90,565 +24%
RCM
21
RA Capital Management
Massachusetts
$75M 455,173 +455,173 New
Northern Trust
22
Northern Trust
Illinois
$73.2M 444,158 +31,984 +8%
FCM
23
Farallon Capital Management
California
$65.9M 400,000 +156,500 +64%
Geode Capital Management
24
Geode Capital Management
Massachusetts
$62.7M 380,896 +72,790 +24%
ORI
25
Oak Ridge Investments
Illinois
$57.1M 346,597 -390,112 -53%
1
2 3 4 5